Jacobs Levy Equity Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-20,356
| Closed | -$10.9K | – | 1230 |
|
|
2024
Q4 | $10.9K | Sell |
20,356
-393,913
| -95% | -$211K | ﹤0.01% | 926 |
|
|
2024
Q3 | $729K | Buy |
414,269
+117,255
| +39% | +$206K | ﹤0.01% | 781 |
|
|
2024
Q2 | $348K | Buy |
297,014
+254,565
| +600% | +$298K | ﹤0.01% | 878 |
|
|
2024
Q1 | $384K | Buy |
+42,449
| New | +$384K | ﹤0.01% | 836 |
|
|
2020
Q4 | – | Sell |
-84,626
| Closed | -$1.09M | – | 1108 |
|
|
2020
Q3 | $1.09M | Buy |
84,626
+24,706
| +41% | +$317K | 0.01% | 646 |
|
|
2020
Q2 | $609K | Buy |
59,920
+40,027
| +201% | +$407K | 0.01% | 757 |
|
|
2020
Q1 | $162K | Sell |
19,893
-18,349
| -48% | -$149K | ﹤0.01% | 913 |
|
|
2019
Q4 | $330K | Buy |
+38,242
| New | +$330K | ﹤0.01% | 839 |
|